ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Recurrence
Preleukemia
Hematologic Cancer

Acute Myeloid Leukemia (AML) trials near Sevilla, AN, ESP:

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Daunorubicin
Drug: Azacitidine (AZA)

Phase 3

Kura Oncology

Seville, Spain and 52 other locations

will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...

Active, not recruiting
Acute Leukemia of Ambiguous Lineage
Mixed Phenotype Acute Leukemia
Drug: Ziftomenib
Drug: Itraconazole

Phase 1, Phase 2

Kura Oncology

Seville, Spain and 43 other locations

when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...

Active, not recruiting
Acute Myeloid Leukemia (AML)
High-risk Myelodysplastic Syndrome
Drug: RVU120

Phase 2

Ryvu Therapeutics

Sevilla, Spain and 40 other locations

and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndro...

Enrolling
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Drug: Azacitidine
Drug: Venetoclax

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seville, Spain and 15 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seville, Spain and 247 other locations

of JNJ-90189892 in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) or R/R higher-risk...

Enrolling
Leukemia, Myeloid, Acute
Myelodysplastic Neoplasms
Drug: Venetoclax (VEN)
Drug: JNJ-90189892

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Seville, Spain and 8 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Seville, Spain and 288 other locations

administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: RVU120

Phase 2

Ryvu Therapeutics

Sevilla, Spain and 36 other locations

monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodyspla...

Enrolling
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Drug: BGB-11417
Drug: Azacitidine

Phase 1, Phase 2

BeiGene
BeiGene

Seville, Spain and 47 other locations

with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...

Enrolling
Acute Myeloid Leukemias
Drug: SNDX-5613
Drug: Chemotherapy Regimen

Phase 1

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Seville, Spain and 45 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems